The post Analyst Predicts a $10M Bitcoin as Bitcoin Hyper Catches Steam appeared on BitcoinEthereumNews.com. Analyst Predicts a $10M Bitcoin as Bitcoin Hyper Catches Steam Sign Up for Our Newsletter! For updates and exclusive offers enter your email. As a crypto writer, Bogdan’s responsibilities are split between researching and writing articles and entertaining the team with his humor bordering on the politically incorrect, an aspiring Bill Burr, if you will. Thanks to his 12+ years of writing experience in just as many fields, including tech, cybersecurity, modelling, fitness, crypto, and other topics-that-shall-not-be-named, he’s become a genuine asset to the team. While his position as a senior writer at PrivacyAffairs thought him valuable lessons about the power of self-management, his entire writing career was and is an exercise in self-improvement. Now, he’s ready to sink his teeth into crypto and teach people how to take control of their own money on the blockchain. With fiat as an eternally devaluing currency, Bitcoin and altcoins seem like the best-fitting alternative for Bogdan. Bogdan’s biggest professional accomplishment, aside from securing a position as a main writer for Bitcoinist, was his 5-year run as a writing manager at Blackwood Productions, where he coordinated a team of four writers. During that time, he learned the value of teamwork and that of creating a working environment that breeds efficiency, positivity, and friendship. This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy Center or Cookie Policy. I Agree Source: https://bitcoinist.com/analyst-predicts-bitcoin-to-10m-bitcoin-hyper-gains/The post Analyst Predicts a $10M Bitcoin as Bitcoin Hyper Catches Steam appeared on BitcoinEthereumNews.com. Analyst Predicts a $10M Bitcoin as Bitcoin Hyper Catches Steam Sign Up for Our Newsletter! For updates and exclusive offers enter your email. As a crypto writer, Bogdan’s responsibilities are split between researching and writing articles and entertaining the team with his humor bordering on the politically incorrect, an aspiring Bill Burr, if you will. Thanks to his 12+ years of writing experience in just as many fields, including tech, cybersecurity, modelling, fitness, crypto, and other topics-that-shall-not-be-named, he’s become a genuine asset to the team. While his position as a senior writer at PrivacyAffairs thought him valuable lessons about the power of self-management, his entire writing career was and is an exercise in self-improvement. Now, he’s ready to sink his teeth into crypto and teach people how to take control of their own money on the blockchain. With fiat as an eternally devaluing currency, Bitcoin and altcoins seem like the best-fitting alternative for Bogdan. Bogdan’s biggest professional accomplishment, aside from securing a position as a main writer for Bitcoinist, was his 5-year run as a writing manager at Blackwood Productions, where he coordinated a team of four writers. During that time, he learned the value of teamwork and that of creating a working environment that breeds efficiency, positivity, and friendship. This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy Center or Cookie Policy. I Agree Source: https://bitcoinist.com/analyst-predicts-bitcoin-to-10m-bitcoin-hyper-gains/

Analyst Predicts a $10M Bitcoin as Bitcoin Hyper Catches Steam



















































Source: https://bitcoinist.com/analyst-predicts-bitcoin-to-10m-bitcoin-hyper-gains/

Market Opportunity
Hyperlane Logo
Hyperlane Price(HYPER)
$0.13335
$0.13335$0.13335
-1.15%
USD
Hyperlane (HYPER) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26